Medicare Enrolled

Dr. Sheri Hsu, M.D.

Internal Medicine · La Quinta, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
79215 CORPORATE CENTER DR STE 120, La Quinta, CA 92253
7607711111
In practice since 2007 (18 years)
NPI: 1831300722 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hsu

Dr. Sheri Hsu is an internal medicine specialist in La Quinta, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hsu performed 53,709 Medicare services across 1,726 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hsu received a total of $40,692 from 55 pharmaceutical and/or device companies across 1876 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hsu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in CA $40,692 industry payments

Medicare Practice Summary

Medicare Utilization ↗
53,709
Medicare services
Top 0% in CA for internal medicine
1,726
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,984 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
50,004 $4 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,802 $93 $225
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
423 $27 $40
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
279 $1 $10
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
227 $74 $175
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
226 $65 $125
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
201 $63 $130
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
201 $122 $340
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
112 $10 $50
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
76 $139 $300
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
65 $53 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $62 $160
Injection, methylprednisolone acetate, 40 mg 24 $5 $16
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
23 $36 $125
New patient office visit, complex (60-74 min) 22 $168 $420
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$40,692
Total received (2018-2024)
Avg $5,813/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
1,876
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$40,455 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$237 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,654
2023
$7,001
2022
$6,487
2021
$4,534
2020
$4,281
2019
$5,963
2018
$4,771

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,448
ABBVIE INC.
$1,256
UCB, Inc.
$742
Mallinckrodt Hospital Products Inc.
$707
GlaxoSmithKline, LLC.
$432
AstraZeneca Pharmaceuticals LP
$432
Janssen Biotech, Inc.
$402
Boehringer Ingelheim Pharmaceuticals, Inc.
$356
Aurinia Pharma U.S., Inc.
$346
Novartis Pharmaceuticals Corporation
$318
Lilly USA, LLC
$297
PFIZER INC.
$207
ANI Pharmaceuticals, Inc.
$158
Almatica Pharma LLC
$114
Radius Health, Inc.
$112
E.R. Squibb & Sons, L.L.C.
$104
SOBI, INC
$72
Fresenius Kabi USA, LLC
$54
Sandoz Inc.
$38
SCILEX PHARMACEUTICALS INC.
$36
Alexion Pharmaceuticals, Inc.
$24
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$7,890
ABBVIE INC.
$4,077
UCB, Inc.
$2,987
Mallinckrodt Hospital Products Inc.
$2,350
PFIZER INC.
$2,153
Novartis Pharmaceuticals Corporation
$1,869
GlaxoSmithKline, LLC.
$1,768
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,711
Janssen Biotech, Inc.
$1,566
Lilly USA, LLC
$1,553
Horizon Therapeutics plc
$1,493
AbbVie, Inc.
$1,245
AstraZeneca Pharmaceuticals LP
$1,184
Aurinia Pharma U.S., Inc.
$1,091
AbbVie Inc.
$1,083
E.R. Squibb & Sons, L.L.C.
$1,005
Celgene Corporation
$905
Radius Health, Inc.
$843
Mallinckrodt Enterprises LLC
$519
GENZYME CORPORATION
$491
Horizon Pharma plc
$468
Genentech USA, Inc.
$323
Mallinckrodt LLC
$251
Sobi, Inc
$198
Cumberland Pharmaceuticals, Inc.
$168
ANI Pharmaceuticals, Inc.
$158
SOBI, INC
$157
Actelion Pharmaceuticals US, Inc.
$136
Almatica Pharma LLC
$114
IDORSIA PHARMACEUTICALS US INC
$104
Takeda Pharmaceuticals U.S.A., Inc.
$99
Alexion Pharmaceuticals, Inc.
$92
Fresenius Kabi USA, LLC
$85
Sandoz Inc.
$69
Gilead Sciences, Inc.
$46
Antares Pharma, Inc.
$39
SCILEX PHARMACEUTICALS INC.
$36
Kyowa Kirin, Inc.
$34
ARBOR PHARMACEUTICALS, INC.
$31
Fidia Pharma USA Inc.
$28
ASSERTIO THERAPEUTICS, INC.
$24
Hikma Pharmaceuticals USA
$23
TerSera Therapeutics LLC
$21
FIDIA PHARMA USA INC.
$20
Kiniksa Pharmaceuticals, Ltd.
$19
EISAI INC.
$19
Bioventus LLC
$18
Oxford Immunotec USA Inc
$18
BioDelivery Sciences International, Inc.
$18
Metacel Pharmaceuticals LLC
$17
Eisai Inc.
$17
Mission Pharmacal Company
$17
HOSPIRA, INC.
$15
Assertio Therapeutics, Inc.
$15
Ironwood Pharmaceuticals, Inc
$14
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Aimovig · Amitiza · Aquoral · Arcalyst · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · Bimzelx · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · Dayvigo · EVENITY · EVUSHELD · Edarbi · Enbrel · Gralise · HUMIRA · HYMOVIS · HYRIMOZ · Horizant · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · JARDIANCE · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · Otrexup · Ozobax · PENNSAID · PRIALT · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · RAYOS · REDITREX · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Supartz · T-SPOT.TB8 · TAKHZYRO · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · ULTOMIRIS · UPTRAVI · Uloric · Ultomiris · XELJANZ · ZIPSOR · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in CA.

Looking for an internal medicine specialist in La Quinta?
Compare internal medicine physicians in the La Quinta area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
211
Per 100K population
8.6
County median income
$89,672
Nearest hospital
JOHN F KENNEDY MEMORIAL HOSPITAL
4.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hsu is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 4% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hsu experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hsu performed 50,004 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsu receive payments from pharmaceutical companies?
Yes. Dr. Hsu received a total of $40,692 from 55 companies across 1,876 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsu's costs compare to other internal medicine physicians in La Quinta?
Dr. Hsu's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →